Among the 34 patients with sufficient material with tumor cells and stroma before and after CCRT, one, 16, or 17 patients had decreased, unchanged, or increased stromal CD8+ lymphocytes after CCRT, respectively (Fig. 2c). Here, CD8A is linked to neoplasm.